• 1. Shenzhen University Medical School, Shenzhen 518061, China;
  • 2. Department of Ophthalmology, Second People’s Hospital of Shenzhen, Shenzhen 518025, China;
  • 3. Shantou University Medical College, Shantou 515041, China;
  • 4. Department of Ophthalmology, Shenzhen Children’s Hospital, Shenzhen 518034, China;
Dou Xiaoyan, Email: douxy08@163.com
Export PDF Favorites Scan Get Citation

Objective To observe alterations in center retinal thickness (CRT) in patients diagnosed with central retinal artery occlusion (CRAO) before and after undergoing superselective arterial thrombolysis (IAT) treatment. Methods A retrospective clinical study. From August 2022 to September 2023, 12 patients (12 eyes) diagnosed with CRAO and treated with IAT at the ophthalmology department of Shenzhen Second People's Hospital. Among these patients, there were 8 males (8 eyes) and 4 females (4 eyes), all experiencing unilateral onset. The mean age was (47.00±15.06) years. The mean duration from onset to thrombolysis was (30.00±30.42) h. All eyes underwent best corrected visual acuity (BCVA) and optical coherence tomography (OCT) assessments; additionally, 6 eyes underwent Fluorescein fundus angiography (FFA). BCVA assessments were conducted using a standard logarithmic chart and transformed into logarithm of the minimum angle of resolution (logMAR) values for statistical analysis. The OCT measured CRT at various locations around the macular fovea (M), including upper (S1, S3), lower (I1, I3), nasal (N1, N3), and temporal (T1, T3) areas at 1 mm and 3 mm distances from the fovea. CRT was defined as the vertical distance between the inner retinal boundary membrane and the inner interface of the retinal pigment epithelial layer. Pre- and post-IAT examinations were performed using the same equipment and methodologies within a 24-hour interval. Changes in CRT at different macular points were compared and observed, while arterial imaging time changes were assessed in 6 eyes that underwent FFA. Paired t-tests were utilized to analyze logMAR BCVA, CRT at different locations, and arterial imaging time pre- and post-treatment. Results Prior to IAT treatment, the logMAR BCVA for the affected eye was 3.48±1.42, while the arterial imaging time for the 6 eyes undergoing FFA examination was (27.50±5.47) s. After 24 hours, the logMAR BCVA had improved to 2.35±1.59 for the affected eye, with 9 eyes showing varying degrees of BCVA improvement. The arterial imaging time was (24.17±7.28) s post-treatment. The differences in logMAR BCVA and arterial imaging time before and after treatment were found to be statistically significant (t=2.489, 3.262; P<0.05). Additionally, the comparison of CRT at S3 (t=2.871), I1 (t=2.325), and T3 (t=3.446) before and after treatment yielded statistically significant differences (P<0.05). Conversely, the comparison of CRT at S1 (t=1.879), I3 (t=1.915), N1 (t=2.001), N3 (t=1.987), T1 (t=2.180), and M (t=-0.490) showed no statistically significant differences (P>0.05). Conclusions IAT treatment for CRAO has been shown to be effective in achieving therapeutic effects by reducing CRT in the macular area. However, the short-term improvement in retinal edema in the macular area is limited.

Citation: Luo Tianyi, Yao Yufeng, Song Qiyuan, Dou Xiaoyan. The changes in macular thickness at multiple locations before and after thrombolysis in patients with central retinal artery occlusion. Chinese Journal of Ocular Fundus Diseases, 2024, 40(4): 268-272. doi: 10.3760/cma.j.cn511434-20231225-00508 Copy

  • Previous Article

    Key points interpretation of Expert consensus on clinical diagnosis and treatment path of retinal vein occlusion in China
  • Next Article

    Analysis of CEP290 gene variants and clinical phenotypes in a family with Leber congenital amaurosis type 10